Fulcrum Therapeutics
FULC
FULC
38 hedge funds and large institutions have $262M invested in Fulcrum Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 39 → 38 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
38
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.57M | |
| 2 | +$3.39M | |
| 3 | +$1.93M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$962K |
Top Sellers
| 1 | -$3.68M | |
| 2 | -$3.38M | |
| 3 | -$3.12M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.24M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.02M |